Riken Vitamin Yönetim

Yönetim kriter kontrolleri 2/4

Riken Vitamin CEO'su Kazuhiko Yamaki, Jun2016 tarihinde atandı, in görev süresi 8.42 yıldır. şirketin hisselerinin 0.049% doğrudan sahiptir ve bu hisselerin değeri ¥ 37.83M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 3.4 yıldır.

Anahtar bilgiler

Kazuhiko Yamaki

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	8.4yrs
CEO sahipliği	0.05%
Yönetim ortalama görev süresi	3.8yrs
Yönetim Kurulu ortalama görev süresi	3.4yrs

Son yönetim güncellemeleri

Recent updates

Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50

Mar 15

Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50

Mar 01

CEO

Kazuhiko Yamaki (65 yo)

8.4yrs

Görev süresi

Mr. Kazuhiko Yamaki serves as the President at Riken Vitamin Co., Ltd. since June 2016 and served as its Executive Officer since July 2006. Mr. Yamaki served as its Managing Director at Riken Vitamin Co.,...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kazuhiko Yamaki	President & Representative Director	8.4yrs	Veri yok	0.049% ¥ 37.8m
Hiroyuki Hashino	Accounting Manager	no data	Veri yok	Veri yok
Nobuo Dotsu	MD of Administrative	1.4yrs	Veri yok	0.013% ¥ 10.1m
Toshiyuki Tanaka	Executive Officer & GM of Human Resources Department	no data	Veri yok	Veri yok
Takahisa Nakano	Senior MD & Representative Director	2.4yrs	Veri yok	0.033% ¥ 25.2m
Atsushi Mochizuki	MD of International Business Department & Director	5.4yrs	Veri yok	0.013% ¥ 10.1m
Takumi Aoki	Managing Executive Officer	2.8yrs	Veri yok	Veri yok
Shinichi Koyama	Managing Executive Officer	no data	Veri yok	Veri yok
Masaaki Nakano	Managing Executive Officer & GM of Food Sales Division	4.8yrs	Veri yok	Veri yok
Yoshiya Inoue	Chief of PR & IR Office - Corporate Planning Department	no data	Veri yok	Veri yok
Takahiro Tomitori	Head of Corporate Strategy & Director	no data	Veri yok	0.0033% ¥ 2.5m

3.8yrs

Ortalama Görev Süresi

64yo

Ortalama Yaş

Deneyimli Yönetim: 4526 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kazuhiko Yamaki	President & Representative Director	14.4yrs	Veri yok	0.049% ¥ 37.8m
Nobuo Dotsu	MD of Administrative	2.4yrs	Veri yok	0.013% ¥ 10.1m
Takahisa Nakano	Senior MD & Representative Director	12.4yrs	Veri yok	0.033% ¥ 25.2m
Atsushi Mochizuki	MD of International Business Department & Director	2.4yrs	Veri yok	0.013% ¥ 10.1m
Takahiro Tomitori	Head of Corporate Strategy & Director	3.4yrs	Veri yok	0.0033% ¥ 2.5m
Eiichi Kato	Director	3.4yrs	Veri yok	0.020% ¥ 15.1m
Satoshi Fujinaga	Independent Outside Director	7.4yrs	Veri yok	0.013% ¥ 10.1m
Hisayoshi Sueyoshi	Independent External Director	7.4yrs	Veri yok	0.0099% ¥ 7.6m
Shinichi Hirano	Independent Outside Director	3.4yrs	Veri yok	0.0033% ¥ 2.5m
Wataru Sueyoshi	Independent Outside Director	3.4yrs	Veri yok	Veri yok
Ayumi Ujihara	Independent Outside Director	1.4yrs	Veri yok	Veri yok

3.4yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 4526 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.4 yıldır).

Riken Vitamin Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Riken Vitamin Co., Ltd., Annual General Meeting, Jun 25, 2024

Riken Vitamin Co., Ltd., Annual General Meeting, Jun 27, 2023

Riken Vitamin Co., Ltd., Annual General Meeting, Jun 28, 2022

High number of new directors

Recent updates

Riken Vitamin's (TSE:4526) Earnings Are Of Questionable Quality

Second quarter 2025 earnings released: EPS: JP¥29.15 (vs JP¥48.72 in 2Q 2024)

Upcoming dividend of JP¥40.50 per share

Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Riken Vitamin Co., Ltd. to Report Q2, 2025 Results on Nov 13, 2024

Riken Vitamin (TSE:4526) Has Announced A Dividend Of ¥40.50

First quarter 2025 earnings released: EPS: JP¥78.07 (vs JP¥63.02 in 1Q 2024)

Investor sentiment deteriorates as stock falls 15%

Riken Vitamin (TSE:4526) Will Pay A Dividend Of ¥40.50

Riken Vitamin's (TSE:4526) Dividend Will Be ¥40.50

Final dividend increased to JP¥40.50

Riken Vitamin Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024

Riken Vitamin's (TSE:4526) Promising Earnings May Rest On Soft Foundations

Full year 2024 earnings: EPS and revenues miss analyst expectations

Riken Vitamin Co., Ltd., Annual General Meeting, Jun 25, 2024

Riken Vitamin Co., Ltd. Revises Year-End Dividend Guidance

Upcoming dividend of JP¥44.50 per share

Riken Vitamin (TSE:4526) Has Announced That It Will Be Increasing Its Dividend To ¥44.50

New major risk - Revenue and earnings growth

Riken Vitamin Co., Ltd. to Report Fiscal Year 2024 Results on May 10, 2024

Riken Vitamin Co., Ltd. (TSE:4526) announces an Equity Buyback for 3,000,000 shares, representing 9.14% for ¥7,713 million.

Riken Vitamin (TSE:4526) Is Increasing Its Dividend To ¥44.50

Riken Vitamin Co., Ltd. (TSE:4526) announces an Equity Buyback for 3,000,000 shares, representing 9.14% for ¥7,713 million.

Third quarter 2024 earnings released: EPS: JP¥73.50 (vs JP¥53.19 in 3Q 2023)

Riken Vitamin Co., Ltd. Revised Earnings Guidance for the Fiscal Year Ending March 31, 2024

Riken Vitamin Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: JP¥48.72 (vs JP¥40.03 in 2Q 2023)

Upcoming dividend of JP¥29.50 per share at 2.6% yield

Riken Vitamin Co., Ltd. to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings released: EPS: JP¥63.02 (vs JP¥55.88 in 1Q 2023)

Riken Vitamin Co., Ltd. Provides Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year Ending March 31, 2024

Riken Vitamin Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings released: EPS: JP¥196 (vs JP¥658 in FY 2022)

Riken Vitamin Co., Ltd., Annual General Meeting, Jun 27, 2023

Upcoming dividend of JP¥29.00 per share at 2.8% yield

Riken Vitamin Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

Third quarter 2023 earnings released: EPS: JP¥53.19 (vs JP¥77.74 in 3Q 2022)

Riken Vitamin Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023

Second quarter 2023 earnings released: EPS: JP¥40.03 (vs JP¥45.55 in 2Q 2022)

Second quarter 2023 earnings released: EPS: JP¥40.02 (vs JP¥45.55 in 2Q 2022)

Now 21% undervalued

Upcoming dividend of JP¥23.00 per share

Riken Vitamin Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings released: EPS: JP¥55.88 (vs JP¥478 in 1Q 2022)

Riken Vitamin Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings released: EPS: JP¥658 (vs JP¥49.34 loss in FY 2021)

Riken Vitamin Co., Ltd., Annual General Meeting, Jun 28, 2022

High number of new directors

Riken Vitamin Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥21.00 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS JP¥45.55 (vs JP¥30.59 loss in 2Q 2021)

Upcoming dividend of JP¥21.00 per share

Full year 2021 earnings released: JP¥49.34 loss per share (vs JP¥272 loss in FY 2020)

Qingdao Agricultural By-Products Co., Ltd. agreed to acquire Qingdao Fusheng Foodstuffs Co., Ltd. from Riken Vitamin Co., Ltd. (TSE:4526) for CNY 1.

Full year 2021 earnings released: JP¥49.34 loss per share (vs JP¥272 loss in FY 2020)

Upcoming dividend of JP¥21.00 per share

Riken Vitamin Co., Ltd. to Report Fiscal Year 2021 Results on May 14, 2021

New 90-day low: JP¥1,314

Third quarter 2021 earnings released: EPS JP¥26.25 (vs JP¥2.20 loss in 3Q 2020)

Riken Vitamin Co., Ltd. to Report Q3, 2021 Results on Feb 15, 2021

Riken Vitamin Co., Ltd. to Report Q2, 2021 Results on Nov 16, 2020

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş